A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation
-
Nevens, Frederik (University Hospitals Leuven (Bèlgica))
;
Gustot, Thierry (C.U.B. Erasme Hospital) ;
Laterre, Pierre-François (Cliniques Universitaires Saint-Luc) ;
Lasser, Luc L. (CHU Brugmann) ;
Haralampiev, Lyudmil E. (Multiprofile Hospital for Active Treatment (MEDICA), Ruse) ;
Vargas, Victor (Hospital Universitari Vall d'Hebron) ;
Lyubomirova, Desislava (University Multiprofile Hospital for Active Treatment "Georgi Stranski") ;
Albillos, Agustín (Hospital Universitario Ramón y Cajal (Madrid)) ;
Najimi, Mustapha (Institute of Experimental and Clinical Research, Brussels) ;
Michel, Sébastien (Promethera Biosciences, Mont-Saint-Guibert) ;
Stoykov, Ivaylo (Promethera Biosciences, Mont-Saint-Guibert) ;
Gordillo, Noelia (Promethera Biosciences, Mont-Saint-Guibert) ;
Vainilovich, Yelena (Promethera Biosciences, Mont-Saint-Guibert) ;
Barthel, Virginie (Promethera Biosciences, Mont-Saint-Guibert) ;
Clerget-Chossat, Nathalie (Promethera Biosciences, Mont-Saint-Guibert) ;
Sokal, Etienne M. (Cliniques Universitaires Saint-Luc, UCLouvain, Pediatric Hepatology & Gastroenterology Unit) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
